Latest News

Oct 4, 2018

Propanc Biopharma Initiates European Validation of its Lead Patent

MELBOURNE, Australia, Oct. 4, 2018 /PRNewswire/ -- Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and…

View All Press Releases